CFO4Life Group
MBIO icon

CFO4Life Group’s Mustang Bio MBIO Stock Holding History

CFO4Life Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.5K Hold
33,510
– – ﹤0.01% 240
2026
Q2 		$23.5K Buy
33,510
+13,049
+64% +$9.27K ﹤0.01% 236
2026
Q1 		$14.9K Buy
20,461
+7,500
+58% +$7.06K ﹤0.01% 208
2025
Q4 		$12.7K Buy
12,961
+2,500
+24% +$3.3K ﹤0.01% 240
2025
Q3 		$15.9K Buy
+10,461
New +$18.6K ﹤0.01% 233

Other funds holding MBIO

Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Cullen/Frost Bankers
Cullen/Frost Bankers San Antonio, Texas $10.2B AUM 22.58% 1-Year Est. Return
Global Retirement Partners
Global Retirement Partners San Rafael, California $7.1B AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

CFO4Life Group's MBIO Position: Q3 2026 in Review

CFO4Life Group held its Mustang Bio (MBIO) position steady in Q3 2026 at 33,510 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #240.

CFO4Life Group first reported a position in MBIO in Q3 2025 and has held it in 5 quarters since. The position peaked at $23.5K in Q2 2026. 14 funds tracked by Wall St. Rank hold MBIO as of Q3 2026.

  • CFO4Life Group held 33,510 shares of Mustang Bio worth $15.5K as of Q3 2026.
  • CFO4Life Group left its Mustang Bio share count unchanged in Q3 2026.
  • Mustang Bio made up ﹤0.01% of CFO4Life Group's portfolio in Q3 2026, its #240 holding.
  • CFO4Life Group first reported a position in Mustang Bio in Q3 2025 and has held it in 5 quarters since.
  • CFO4Life Group's Mustang Bio position peaked at $23.5K in Q2 2026.
  • 14 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2026.

Based on CFO4Life Group's 13F filing for Q3 2026, filed 12 Nov 2026.